SCHEMBL12687065

SCHEMBL12687065

CCCCOc1ccc(CO)c(C(=O)OC)c1

nearest known ligand 0.51

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ MAOA P21397 1/20 0.51
▸ MAOB P27338 1/20 0.51
▸ PLA2G2A P14555 2/20 0.50
▸ PTPN11 Q06124 3/20 0.46
▸ ALPL P05186 1/20 0.46
▸ MAPT P10636 1/20 0.45
▸ ALDH1A1 P00352 2/20 0.44
▸ KDM4E B2RXH2 2/20 0.44
▸ HPGD P15428 1/20 0.44
▸ L3MBTL1 Q9Y468 1/20 0.44
▸ MEN1 O00255 1/20 0.44
▸ KMT2A Q03164 1/20 0.44
▸ CYP1A2 P05177 2/20 0.44
▸ CYP2C19 P33261 2/20 0.44
▸ SMN1; SMN2 Q16637 1/20 0.44
▸ CYP2D6 P10635 1/20 0.43
▸ CYP2C9 P11712 1/20 0.43
▸ CNR2 P34972 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21543811 0.84 MAOA (0.55) MAOAMAOBPLA2G2APTPN11ALPL
SCHEMBL3230860 0.83 KDM4E (0.61) PLA2G2AMAPTALDH1A1KDM4EHPGD
SCHEMBL13162403 0.82 MAOA (0.53) MAOAMAOBPLA2G2APTPN11ALPL
SCHEMBL8085882 0.82 MAOA (0.60) MAOAMAOBPLA2G2APTPN11
SCHEMBL12587312 0.82 CA12 (0.56) MAOAMAOBPLA2G2APTPN11ALPL
SCHEMBL27141409 0.81 PLA2G2A (0.46) MAOAMAOBPLA2G2AMAPTALDH1A1
SCHEMBL14473947 0.81 MAOA (0.52) MAOAMAOBPLA2G2APTPN11ALPL
SCHEMBL12687133 0.81 MAOA (0.52) MAOAMAOBPLA2G2APTPN11ALPL
SCHEMBL4257305 0.81 ALDH1A1 (0.56) MAOAMAOBPLA2G2APTPN11ALPL
SCHEMBL16836640 0.81 MAOA (0.62) MAOAMAOBPTPN11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012102985-A1 ISOQUINOLINE COMPOUNDS AND METHODS FOR TREATING HIV GLAXOSMITHKLINE LLC (US) 2012-08-02 — — WO disclosed
Send feedback